Phase I study of adjuvant immunotherapy with autologous tumor-infiltrating lymphocytes in locally advanced cervical cancer.
J Clin Invest
; 132(15)2022 08 01.
Article
in En
| MEDLINE
| ID: mdl-35727633
Full text:
1
Collection:
01-internacional
Health context:
6_ODS3_enfermedades_notrasmisibles
Database:
MEDLINE
Main subject:
Uterine Cervical Neoplasms
/
Immunotherapy
Limits:
Female
/
Humans
Language:
En
Journal:
J Clin Invest
Year:
2022
Document type:
Article